Immunomodulatory therapy in genetic mouse models of progressive multiple sclerosis

被引：0
|
作者：
Groh, J. [1 ]
Hoerner, M. [1 ]
Buttmann, M. [2 ]
Martini, R. [1 ]
机构：
[1] Univ Hosp Wuerzburg, Dept Neurol, Dev Neurobiol, Wurzburg, Germany
[2] Univ Hosp Wuerzburg, Dept Neurol, Wurzburg, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P430
引用
收藏
页码：177 / 177
页数：1
相关论文
共 50 条
  • [1] Immunomodulatory therapy of multiple sclerosis
    Weber, F
    NERVENHEILKUNDE, 2000, 19 (06) : 310 - 315
  • [2] Inappropriate use of immunomodulatory therapy in severely disabled patients with progressive multiple sclerosis
    Lonergan, Roisin
    Doyle, Katie
    Duggan, Marguerite
    Jordan, Sinead
    Hutchinson, Michael
    Tubridy, Niall
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 : S53 - S53
  • [3] Immunomodulatory effects of melatonin on neuroinflammation and neurodegeneration in the preclinical mouse model of progressive multiple sclerosis
    Alvarez Lopez, Ana Isabel
    Bejarano-Hernando, Ignacio
    Santos-Sanchez, Guillermo
    Cruz-Chamorro, Ivan
    Ponce-Espana, Eduardo
    Parralejo-Ayala, Ivan
    Judith Lardone, Patricia
    Carrillo-Vico, Antonio
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 945 - 945
  • [4] Escalating immunomodulatory therapy of multiple sclerosis
    Büttner, U
    Chofflon, M
    Hess, K
    Kappos, L
    Kesselring, J
    Ludin, H
    Rihs, F
    Schluep, M
    Vaney, C
    Baumhackl, U
    Berger, T
    Freimüller, O
    Hartung, HP
    Kollegger, W
    Kristoferitsch, W
    Vass, K
    Lassmann, H
    Markut, S
    Altenkirch, H
    Boese, J
    Gehlen, W
    Goebels, N
    Gold, R
    Haas, J
    Haferkamp, G
    Heidenreic, F
    Heitmann, R
    Hohlfeld, R
    Jügelt, E
    Kölmel, H
    König, N
    Lowitzsch, K
    Manegold, U
    Mertin, J
    Pette, M
    Poser, S
    Sailer, J
    Schack, G
    Schulz, M
    Seidel, D
    Stark, E
    Stoll, G
    Weinrich, W
    Wiethölter, H
    Zettl, U
    Zipp, F
    Zschenderlein, R
    Rieckmann, P
    Toyka, KV
    Chan, A
    NERVENARZT, 1999, 70 (04): : 371 - 386
  • [5] Contemporary immunomodulatory therapy for multiple sclerosis
    Rudick, RA
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2001, 21 (04) : 284 - 291
  • [6] A mouse model of progressive multiple sclerosis
    Avila, R. L.
    Chmura, D.
    Lunn, S.
    Ramboz, S.
    Battapady, H.
    Dejesus, H.
    Erokwu, C.
    Harris, P.
    Elmer, T.
    Medicetty, S.
    Trapp, B.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 802 - 802
  • [7] Immunomodulatory therapy in the early phases of multiple sclerosis
    Chan, A
    Rieckmann, P
    Gold, R
    NERVENHEILKUNDE, 2001, 20 (04) : 237 - 243
  • [8] Pregnancy and immunomodulatory therapy in multiple sclerosis patients
    Hoffmann, L. A.
    Kuempfel, T.
    Heer, I.
    Hohlfeld, R.
    NERVENARZT, 2006, 77 (06): : 663 - +
  • [9] Challenge of progressive multiple sclerosis therapy
    Thompson, Alan J.
    CURRENT OPINION IN NEUROLOGY, 2017, 30 (03) : 237 - 240
  • [10] Immunomodulatory Roles of VIP and PACAP in Models of Multiple Sclerosis
    Abad, Catalina
    Waschek, James A.
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (10) : 1025 - 1035
12345